The novel choline kinase inhibitor ICL-CCIC-0019 reprograms cellular metabolism and inhibits cancer cell growth.

The glycerophospholipid phosphatidylcholine is the most abundant phospholipid species of eukaryotic membranes and essential for structural integrity and signaling function of cell membranes required for cancer cell growth. Inhibition of choline kinase alpha (CHKA), the first committed step to phosphatidylcholine synthesis, by the selective small-molecule ICL-CCIC-0019, potently suppressed growth of a panel of 60 cancer cell lines with median GI50 of 1.12 μM and inhibited tumor xenograft growth in mice. ICL-CCIC-0019 decreased phosphocholine levels and the fraction of labeled choline in lipids, and induced G1 arrest, endoplasmic reticulum stress and apoptosis. Changes in phosphocholine cellular levels following treatment could be detected non-invasively in tumor xenografts by [18F]-fluoromethyl-[1,2–2H4]-choline positron emission tomography. Herein, we reveal a previously unappreciated effect of choline metabolism on mitochondria function. Comparative metabolomics demonstrated that phosphatidylcholine pathway inhibition leads to a metabolically stressed phenotype analogous to mitochondria toxin treatment but without reactive oxygen species activation. Drug treatment decreased mitochondria function with associated reduction of citrate synthase expression and AMPK activation. Glucose and acetate uptake were increased in an attempt to overcome the metabolic stress. This study indicates that choline pathway pharmacological inhibition critically affects the metabolic function of the cell beyond reduced synthesis of phospholipids

Altered cytochrome 2E1 and 3A P450-dependent drug metabolism in advanced ovarian cancer correlates to tumour-associated inflammation

Background and Purpose Previous work has focussed on changes in drug metabolism caused by altered activity of CYP3A in the presence of inflammation and, in particular, inflammation associated with malignancy. However, drug metabolism involves a number of other P450s, and therefore, we assessed the effect of cancer‐related inflammation on multiple CYP enzymes using a validated drug cocktail. Experimental Approach Patients with advanced stage ovarian cancer and healthy volunteers were recruited. Participants received caffeine, chlorzoxazone, dextromethorphan, and omeprazole as in vivo probes for CYP1A2, CYP2E1, CYP2D6, CYP3A, and CYP2C19. Blood was collected for serum C‐reactive protein and cytokine analysis. Key Results CYP2E1 activity was markedly up‐regulated in cancer (6‐hydroxychlorzoxazone/chlorzoxazone ratio of 1.30 vs. 2.75), while CYP3A phenotypic activity was repressed in cancer (omeprazole sulfone/omeprazole ratio of 0.23 vs. 0.49). Increased activity of CYP2E1 was associated with raised serum levels of IL‐6, IL‐8, and TNF‐α. Repression of CYP3A correlated with raised levels of serum C‐reactive protein, IL‐6, IL‐8, and TNF‐α. Conclusions and Implications CYP enzyme activity is differentially affected by the presence of tumour‐associated inflammation, affecting particularly CYP2E1‐ and CYP3A‐mediated drug metabolism, and may have profound implications for drug development and prescribing in oncological settings

Exploring interaction effects in two-component gas mixtures using orthogonal signal correction of ultrasound pulses

Within Sweden and the EU, an increased use of biogas gas and natural gas is encouraged to decrease emission of carbon dioxide. To support more effective manufacturing, distribution, and consumption of energy gases, new methods for the measurement of the calorimetric value or the gas composition are needed. This paper presents a method to extract and visualize variations in ultrasound pulse shape, caused by interaction effects between the constituents of a two-component gas mixture. The method is based on a combination of principal component analysis and orthogonal signal correction. Pulse-echo ultrasound experiments on mixtures of oxygen and ethane in the concentration range from 20% to 80% ethane show that the extracted information could be correlated with the molar fraction of ethane in the mixtureValiderad; 2005; 20060913 (ysko

Scandium sulfate complexation in aqueous solution by dielectric relaxation spectroscopy

Ion association in aqueous solutions of scandium sulfate has been investigated at 25 degrees C and at concentrations from 0.01 to 0.8 M by broadband dielectric spectroscopy over the frequency range 0.2 <or= nu/GHz <or= 89. Detailed analysis of the spectra reveals the presence of both inner- and outer-sphere 1:1 [ScSO 4] (+)(aq) complexes, similar to solutions of other high-valent metal sulfates. Outer-outer-sphere 1:1 complexes are probably also formed, but their contribution is swamped by the presence of higher-order inner-sphere complexes. The latter predominate in the more concentrated solutions, causing major changes to the low-frequency end of the spectrum. The data, while not definitive, are consistent with fac-[Sc(SO 4) 3(OH 2) 3] (3-) as the major species present. The speciation is strikingly different from that recently reported for aluminum sulfate solutions and indicates that the often-postulated similarity between the aqueous chemistry of Al(III) and Sc(III) has to be treated with caution